FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

Article Link: FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with…

Source: FDA New Drug Approvals